Two strains from BioGrowing’s Flora-Focus® series – Bifidobacterium animalis subsp. lactis BL-G101 and Weizmannia coagulans BC-G44 – recently obtained US Self GRAS notice with the support of the CIRS Group. This marks significant international recognition of BioGrowing’s products, offering consumers premium choices, and demonstrates the expertise and professional service capabilities of the CIRS Group.
What is US GRAS notice?
GRAS, or Generally Recognized as Safe, is a key regulatory pathway for the compliance of food ingredients. A product can only receive GRAS notice if it undergoes a thorough review and is unanimously deemed by a qualified panel of experts to meet GRAS standards.
Following a rigorous scientific procedure, the panel concluded that Bifidobacterium animalis subsp. lactis BL-G101 and Weizmannia coagulans BC-G44, produced in accordance with current Good Manufacturing Practices (cGMP), are safe for use as food ingredients in traditional foods at their intended use and dosage levels, qualifying them as GRAS substances.
About BioGrowing
The Flora-Focus® series of probiotics is independently developed and produced by BioGrowing. As one of the first companies in China to engage in large-scale production of probiotics, BioGrowing not only boasts an extensive proprietary strain library but also offers professional probiotic product solutions to its clients. The product functions cover areas such as women’s intimate care, constipation relief, oral health, gut health, weight management, blood sugar management, immune enhancement, and anti-Helicobacter pylori benefits.
Currently, its products have successfully been exported to over 70 countries, including 22 of the 27 EU member states. In 2020, BioGrowing was ranked as one of the top three suppliers in the Asia-Pacific region for immune health and among the top five for digestive health by a third-party data monitoring platform.
BioGrowing embraces the brand core philosophy of “Intelligent Manufacturing, Stable and Reliable.” It is dedicated to probiotic research and innovation, striving towards the vision of becoming a global leader in the probiotic health industry. With the goal of establishing an international century-old enterprise, BioGrowing aims to provide comprehensive product solutions to customers and share the benefits of health with the world.
About CIRS
The food team at CIRS Group was established in 2012 and boasts a professional team specialized in US GRAS notice. We have numerous successful cases in various application fields, including US GRAS notice, new food ingredients, new food additives, new food-related products, synthetic biology foods, EU Novel Food, health foods, and foods for special dietary purposes.
CIRS Group operates a wholly-owned subsidiary in the United States, dedicated to conducting U.S FDA-related notice. Our international certification team is highly experienced and offers efficient turnaround times and competitive pricing. We provide personalized, one-on-one certification consulting services. Feel free to inquire or visit us to learn more about our technical expertise!
Our services
- US FDA GRAS Notice
- US New Dietary Ingredient (NDI) Application
- US FDA Dietary Supplement Structure/Function Claim Notification
- US Food Label/Advertisement Information Review
- US FDA Registration of Food Facilities
- NHC New Food Raw Material Registration in China
- NHC New Food Additive Registration in China
- New Feed and New Feed Additive Application in China
- SAMR Health Food (Dietary Supplement) Registration/Filing in China
- SAMR Food for Special Medical Purpose (FSMP) Registration
- EU Novel Food Application
- Novel Food Application in Australia and New Zealand
